Caplin Point Laboratories Ltd. Financials: Quarterly Results
Revenue
576.45
Cr.
PAT
165.88
Cr.
EBITDA
204.09
Cr.
Caplin Point Laboratories Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 542.77 | 534.04 | 510.22 | 502.45 | 492.96 |
| Total Income From Operations (Cr.) | 542.77 | 534.04 | 510.22 | 502.45 | 492.96 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 204.09 | 201.14 | 184.61 | 176.76 | 177.45 |
| P/L Before Exceptional Items & Tax (Cr.) | 203.91 | 200.98 | 184.43 | 176.59 | 177.27 |
| P/L After Tax from Ordinary Activities (Cr.) | 165.88 | 160.21 | 150.73 | 145.20 | 140.08 |
| Net Profit/Loss For the Period (Cr.) | 165.88 | 160.21 | 150.73 | 145.20 | 140.08 |
| Basic EPS | 21.56 | 20.32 | 20.10 | 18.75 | 18.28 |
FAQs
Caplin Point Laboratories Ltd. announced its quarterly results for Q3 FY2026 on February 5, 2026.
In Q3 FY2026, Caplin Point Laboratories Ltd. are as follows:
Revenue: ₹576.45 crore
Net Profit: ₹165.88 crore.
For Q3 FY2026, Caplin Point Laboratories Ltd. posted ₹576.45 crore in revenue and ₹165.88 crore in net profit.
Past quarterly results for Caplin Point Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.